Company Filing History:

22 out of 12,160

Bayer Aktiengesellschaft

patents

1 out of 32

Troponwerke Gmbh & Co Kg

patents

1 out of 1,248

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

Years Active: 1980-1990

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4891425 - N-glycosylamide derivatives, processes for their preparation and their (1990-01-02),

2. 4855283 - Novel pharmaceutically active (1989-08-08),

3. 4737488 - Immune system-stimulating N-glycosylated ureas and carbamates (1988-04-12),

4. 4710491 - N-glycosylated carboxylic acid derivatives as agents for combating (1987-12-01),

5. 4699899 - Substituted O-sulphonyl-glycosylamides, processes for their preparation (1987-10-13),

6. 4686208 - Phosphorylated glycosyl-amides, -ureas, -carbamates and -thiocarbamates (1987-08-11),

7. 4683222 - N-glycosylated carboxamide derivatives and their use for influencing the (1987-07-28),

8. 4680287 - N-glycosylated carboxamide derivatives as growth-promoters in livestock (1987-07-14),

9. 4631272 - N-acylated 1-alkylamino-1-deoxy-ketose derivatives, a process for their (1986-12-23),

10. 4574122 - Substituted O-acylglycosylamides, pharmaceutical compositions and method (1986-03-04),

11. 4438260 - Sisomicin compounds (1984-03-20),

12. 4393051 - 1-N(Aminopolyhydroxyalkyl)aminoglycoside antibiotics and method of use (1983-07-12),

13. 4380625 - Process for the preparation of purified aminoglycoside antibiotics (1983-04-19),

14. 4336369 - Selectively protected 1-N-(.omega.-aminoalkoxycarbonyl)-sisomicin (1982-06-22),

15. 4335114 - 1-N-Alkylsisomicin derivatives, their production and their medicinal use (1982-06-15),

Title: Peter Stadler: A Trailblazer in Innovation

Introduction:

Peter Stadler, a renowned inventor based in Haan, Germany, is a visionary individual whose passion for innovation has driven him to create groundbreaking inventions that positively impact society. With a total of 24 patents to his name, Stadler stands out as a true pioneer in the world of technology.

Latest Patents:

Among his latest patents is the development of N-glycosylamide derivatives and processes for their preparation. These innovations showcase Stadler's expertise in the field, particularly in the creation of novel pharmaceutically active compounds. One notable patent includes a N-glycosylamide derivative formula that represents his cutting-edge approach to pharmaceutical advancements.

Career Highlights:

Stadler has made significant contributions during his tenure at reputable companies such as Bayer Aktiengesellschaft and Troponwerke GmbH & Co. KG. His innovative spirit and dedication to excellence have not only propelled his own career forward but have also enhanced the technological landscape of the companies he has been a part of.

Collaborations:

Throughout his career, Stadler has collaborated with esteemed professionals in the industry, including Karl G Metzger and Oswald Lockhoff. These partnerships have played a pivotal role in the success of Stadler's inventions, highlighting the importance of teamwork in driving innovation forward.

Conclusion:

In conclusion, Peter Stadler's unwavering commitment to innovation and his remarkable ability to transform ideas into tangible inventions have cemented his legacy as a trailblazer in the world of technology. His diverse portfolio of patents and his impact on society through his creations underscore Stadler's importance in shaping the future of innovative advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com